Kroger Health, the arm of grocer Kroger that runs pharmacies and clinics across the U.S., said on Friday it had revamped its ...
Analyzing Madrigal Pharmaceuticals' potential in the competitive NASH drug market and why it may be right for your portfolio.
Wegovy (semaglutide) is a prescription medication belonging to a group of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. It comes as a liquid solution that you self-inject just ...
For the past year and a half, Tandra Cooper Harris and her husband, Marcus, who both have diabetes, have struggled to fill ...
Talking about weight and weight loss with Johann Hari, an Ozempic user and the author of "Magic Pill: The Extraordinary ...
In recent months, Eli Lilly has continued to delight investors with growth in its share price. Strong sales of the company's ...
Learn about the side effects of Ozempic, Wegovy, Mounjaro and Zepbound, so you can weigh the risks versus benefits.
The Boston startup aims to provide an alternative obesity medicine to GLP-1 drugs, which the CEO said can come with "accessibility, cost, side effects and long-term maintenance" issues. A new ...
Taking a cutting-edge weight-loss drug could help extremely obese patients drop enough pounds to be eligible for bariatric surgery, a new study shows. Patients with extreme obesity -- a BMI of 70 ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. STAT is running a promo this week — you can get 40% ...
Boehringer Ingelheim today announced breakthrough results from a survodutide Phase II trial sub-analysis that demonstrate up to 64.5% of adults with fibrosis stages F2 and F3 (moderate to advanced ...